John H. Weiland's most recent trade in Solventum Corp was a trade of 3,564 Common Stock done . Disclosure was reported to the exchange on May 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Solventum Corp | John H. Weiland | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 3,564 | 3,564 | - | 0 | Common Stock | |
| Solventum Corp | John H. Weiland | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 3,564 | 0 | - | - | Restricted Stock Units | |
| Solventum Corp | John H. Weiland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 3,403 | 3,403 | - | - | Restricted Stock Units | |
| Solventum Corp | John H. Weiland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 3,564 | 3,564 | - | - | Restricted Stock Units | |
| Solventum Corp | John H. Weiland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 1,980 | 5,544 | - | - | Restricted Stock Units | |
| Cardinal Health, Inc. | John H. Weiland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 11,138 (0%) | 0% | 0 | Common Shares | |
| Cardinal Health, Inc. | John H. Weiland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 7,429 (0%) | 0% | 0 | Common Shares |